CAS 872728-81-9
:Dabigatranetexilatmesilat
- Bibr 1048Ms
- Dabigatran Etexilate Mesilate
- Dabigatran Etexilate Methanesulfonate
- Dabigatran etexilate mesylate
- N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester monomethanesulfonat
- Pradaxa
- β-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, methanesulfonate (1:1)
- β-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, monomethanesulfonate
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
Dabigatran Etexilate Mesylate
CAS:Formel:C34H41N7O5·CH4O3SReinheit:>98.0%(HPLC)(T)Farbe und Form:White to Light yellow powder to crystalMolekulargewicht:723.85Dabigatran Etexilate Mesylate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormel:C34H41N7O5·CH4O3SFarbe und Form:White Off-White Yellow PowderMolekulargewicht:723.30503Dabigatran Etexilate Mesylate
CAS:Formel:C35H45N7O8SReinheit:98%Farbe und Form:SolidMolekulargewicht:723.8389Hexyl 2-(4-(((5-((3-Ethoxy-3-Oxopropyl)(Pyridin-2-Yl)Carbamoyl)-1-Methyl-1H-Benzo[d]Imidazol-2-Yl)Methyl)Amino)Benzylidene)Hydrazinecarboxylate Methanesulfonate
CAS:Hexyl 2-(4-(((5-((3-Ethoxy-3-Oxopropyl)(Pyridin-2-Yl)Carbamoyl)-1-Methyl-1H-Benzo[d]Imidazol-2-Yl)Methyl)Amino)Benzylidene)Hydrazinecarboxylate MethanesulfonateFormel:C35H45N7O8SReinheit:98%Molekulargewicht:723.84Dabigatran Etexilate Mesylate
CAS:Dabigatran Etexilate MesylateFormel:C34H41N7O5·CH4O3SReinheit:≥98%Molekulargewicht:723.84Dabigatran Etexilate Mesilate
CAS:Kontrolliertes ProduktFormel:C34H41N7O5·CH4O3SFarbe und Form:NeatMolekulargewicht:723.84Dabigatran Etexilate Mesylate
CAS:Kontrolliertes ProduktApplications Nonpeptide, direct thrombin inhibitor. Antithrombotic.
References Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005),Formel:C34H41N7O5·CH4O3SFarbe und Form:NeatMolekulargewicht:723.84Dabigatran Etexilate Mesylate
CAS:Dabigatran Etexilate Mesylate (BIBR 1048MS) is the orally active prodrug of dabigatran. Dabigatran is a reversible and selective, direct thrombin inhibitor.Formel:C34H41N7O5·CH4O3SReinheit:99.91%Farbe und Form:SolidMolekulargewicht:723.84Dabigatran etexilate mesylate
CAS:Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate methanesulfonateFormel:C35H45N7O8SReinheit:98%Molekulargewicht:723.84Dabigatran etexilate mesylate
CAS:Dabigatran etexilate mesylate is an anticoagulant that is a prodrug of dabigatran, which is not active in the body. It is a synthetic molecule that has been designed to be rapidly converted into dabigatran by esterases in the blood plasma. Dabigatran etexilate mesylate has been shown to have a high bioavailability and low clearance rate, as well as good oral absorption and stability. The drug can be used for people with impaired liver function who are being treated with warfarin or heparin, without any change in dosage requirements. The antidote for dabigatran etexilate mesylate is idarucizumab, which binds to dabigatran in the bloodstream and prevents its binding to thrombin receptors on the surface of blood cells.
Formel:C35H45N7O8SReinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:723.84 g/mol










